Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is FDAs policy regarding patient populations from India? What is acceptable regarding a more homogenous population that may not fully reflect the US?

0
Posted

What is FDAs policy regarding patient populations from India? What is acceptable regarding a more homogenous population that may not fully reflect the US?

0

FDA has a policy on inclusion of foreign patient data for registration of drugs for marketing in USA. There is no negative or positive bias towards India. A white paper on the subject is on our website. Numerous audits of global sponsors and US FDA in India are a testimony to the level of quality. Data from clinical studies in India have been successfully filed with international regulatory agencies. The overall impression is that the data quality in India is usually excellent.

Related Questions

Thanksgiving questions

*Sadly, we had to bring back ads too. Hopefully more targeted.